CAS - CANDESSA AI PLC
Grant of Share Options
· RNS
Summary
Candessa AI granted 4,100,000 options on 28 Oct 2026 (2,100,000 EMI: 2,000,000 at 8.8p, 50,000 at 20p, 50,000 at 25p; 2,000,000 non‑scheme at 30p), all expiring 27 Oct 2031, taking total options to 14,675,000 (11.3% of current share capital, 10.93% on the enlarged capital) with a weighted average exercise price of 37.73p; the grants are aimed at retaining AI/ML talent but create potential dilution risk if exercised.
Announcement
29 October 2026
Candessa AI plc
("Candessa AI" or the "Company")
Grant of Share Options
Candessa AI plc (AIM: CAS), a leading provider of AI-led data infrastructure and machine learning solutions, announces the grant of share options over 4,100,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares”) to certain employees.
Options over 2,100,000 Ordinary Shares were granted under the Company’s Enterprise Management Incentive ("EMI") scheme (the "EMI Options"), and options over 2,000,000 Ordinary Shares were granted as unapproved options outside the scheme (the "Non-Scheme Options").
Schedule of EMI Options:
|
|
Position |
Date of grant |
No. Options granted |
Exercise price |
Expiry date |
|
Employees (various) |
N/A |
28 October 2026 |
2,000,000 50,000 50,000 |
8.8p 20p 25p |
27 October 2031 27 October 2031 27 October 2031
|
Schedule of Non-Scheme Options:
|
|
Position |
Date of grant |
No. Options granted |
Exercise price |
Expiry date |
|
Employee |
N/A |
28 October 2026 |
2,000,000 |
30p |
27 October 2031
|
Following the grant of the Options, the Company now has a total of 14,675,000 share options in issue, which represents 11.3% of the current issued share capital, and will represent 10.93% of the enlarged issued share capital following the admission of the new Ordinary Shares pursuant to the Subscription and the Additional Subscription (each as defined in the Company’s announcement made earlier today). The weighted average exercise price of the 14,675,000 options in issue is 37.73p.
For further information, please visit www.candessa.com or contact:
|
Candessa AI plc Richard Bernstein (CEO) |
richard.bernstein@candessa.com
|
|
Zeus (Nominated Adviser & Broker) David Foreman / James Hornigold |
+44 (0) 20 3829 5000 |
|
CMC Markets (Joint Broker) Doug Crippin |
+44 (0) 20 3003 8632 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.